NYSE : SYK
Stryker Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 311.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 119.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 111.11B |
| Enterprise Value | 123.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 380.69M |
| Shares Outstanding | 380.69M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 9.21% |
| Owned by Institutions (%) | 82.98% |
| Float | 348.14M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 31.08 |
| Forward PE | 18.26 |
| PS Ratio | 4.22 |
| Forward PS | 3.94 |
| PB Ratio | 4.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.30 |
| P/OCF Ratio | 20.40 |
| PEG Ratio | 2.05 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 34.02 |
| EV / Sales | 4.69 |
| EV / EBITDA | 16.41 |
| EV / EBIT | 19.56 |
| EV / FCF | 26.96 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.18 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 2.00 |
| Debt / FCF | 3.37 |
| Interest Coverage | 10.76 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 16.02% |
| Return on Assets (ROA) | 8.35% |
| Return on Invested Capital (ROIC) | 12.47% |
| Return on Capital Employed (ROCE) | 15.47% |
| Weighted Average Cost of Capital (WACC) | 7.83% |
| Revenue Per Employee | $469,643 |
| Profits Per Employee | $64,696 |
| Employee Count | 56,000 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.62 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.49B |
| Effective Tax Rate | 29.18% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -21.03% |
| 50-Day Moving Average | 292.71 |
| 200-Day Moving Average | 323.82 |
| Relative Strength Index (RSI) | 47.98 |
| Average Volume (20 Days) | 2,715,883 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.70M |
| Short Previous Month | 7.67M |
| Short % of Shares Out | 1.50% |
| Short % of Float | 1.64% |
| Short Ratio (days to cover) | 2.15 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 26.30B |
| Gross Profit | 17.28B |
| Operating Income | 6.30B |
| Pretax Income | 5.12B |
| Net Income | 3.62B |
| EBITDA | 7.51B |
| EBIT | 6.30B |
| Earnings Per Share (EPS) | $9.39 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 15.43B |
| Net Cash | -12.16B |
| Net Cash Per Share | -$31.95 |
| Equity (Book Value) | 23.46B |
| Book Value Per Share | 61.62 |
| Working Capital | 7.68B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.45B |
| Capital Expenditures | -873.00M |
| Depreciation & Amortization | 1.21B |
| Net Borrowing | -1.50B |
| Free Cash Flow | 4.57B |
| FCF Per Share | $12.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 65.70% |
| Operating Margin | 23.97% |
| Pretax Margin | 19.45% |
| Profit Margin | 13.78% |
| EBITDA Margin | 28.56% |
| EBIT Margin | 23.97% |
| FCF Margin | 17.39% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $3.52 |
| Dividend Yield | 1.21% |
| Dividend Growth (YoY) | 4.76% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 37.49% |
| FCF Payout Ratio | 29.30% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 1.32% |
| Earnings Yield | 3.22% |
| FCF Yield | 4.12% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $341.37 |
| Price Target Difference | 16.96% |
| Analyst Consensus | Buy |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | 7.29% |
| EPS Growth Forecast (3Y) | 9.97% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 17, 2004 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |